Showing results (91-100 of 308) with videos related to
Sort By:
Pageof 31
Human Gene Therapy|September 1, 2006
Amelioration of arthritis by intraarticular dominant negative Ikk beta gene therapy using adeno-associated virus type 5Sander W Tas, Janik Adriaansen, Najat Hajji, et al.Journal of Neuroimmunology|June 13, 2012
Sustained Rap1 activation in autoantigen-specific T lymphocytes attenuates experimental autoimmune encephalomyelitisGabriela Franco Salinas, Sarah Krausz, Wendy Dontje, et al.Plos One|March 17, 2016
Smelling the Diagnosis: The Electronic Nose as Diagnostic Tool in Inflammatory Arthritis. A Case-Reference StudyMarjolein P Brekelmans, Niki Fens, Paul Brinkman, et al.Annals of the Rheumatic Diseases|May 10, 2014
JNK-dependent downregulation of FoxO1 is required to promote the survival of fibroblast-like synoviocytes in rheumatoid arthritisAleksander M Grabiec, Chiara Angiolilli, Linda M Hartkamp, et al.The Journal of Rheumatology|September 3, 2011
Synovial tissue analysis for the discovery of diagnostic and prognostic biomarkers in patients with early arthritisMaria J H de Hair, Leonard C Harty, Danielle M Gerlag, et al.Annals of the Rheumatic Diseases|September 1, 2017
Sirukumab for rheumatoid arthritis: the phase III SIRROUND-D studyTsutomu Takeuchi, Carter Thorne, George Karpouzas, et al.Arthritis and Rheumatism|November 1, 2008
Identification of interleukin-7 as a candidate disease mediator in spondylarthritisMarkus Rihl, Herbert Kellner, Wolfgang Kellner, et al.Annals of the Rheumatic Diseases|January 31, 2007
Activated complement components and complement activator molecules on the surface of cell-derived microparticles in patients with rheumatoid arthritis and healthy individualsEva Biró, Rienk Nieuwland, Paul P Tak, et al.The American Journal of Pathology|February 23, 2008
Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profilesM Cristina Lebre, Sarah L Jongbloed, Sander W Tas, et al.Plos One|February 6, 2014
Safety with ocrelizumab in rheumatoid arthritis: results from the ocrelizumab phase III programPaul Emery, William Rigby, Paul P Tak, et al.Pageof 31